Fundz

Booster Therapeutics raised $15M in an angel funding round led by Apollo Health Ventures and Novo Holdings to develop proteasome activator medicines for complex diseases.

Oct 10, 2024

Amount Raised

$15 Million

Round Type

Angel

BerlinBiotechnologyHealth CareTherapeutics

Investors

Apollo Health VenturesNovo Holdings

Description

Booster Therapeutics, a biotechnology company, launched with a $15 million financing. The funding, led by Apollo Health Ventures and Novo Holdings, will support the development of therapeutics targeting proteasome activity to treat diseases like Parkinson’s and Alzheimer’s.

Quick answer

Booster Therapeutics raised $15 Million in a Angel round, dated October 10, 2024. Investors: Apollo Health Ventures and Novo Holdings. Booster Therapeutics is based in Berlin, Berlin, Germany.

How much did Booster Therapeutics raise?
Booster Therapeutics raised $15 Million in a Angel round on October 10, 2024.
Who invested in Booster Therapeutics?
Apollo Health Ventures and Novo Holdings are named as investors in this round.
What does Booster Therapeutics do?
Booster Therapeutics is a biotechnology company focused on developing a new class of proteasome activator medicines for treating complex diseases, including neurodegenerative disorders.
Where is Booster Therapeutics based and how big is it?
Booster Therapeutics is based in Berlin, Berlin, Germany. Fundz records about 870 employees.
Who are the decision-makers at Booster Therapeutics?
Fundz holds 1 contact at Booster Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Booster Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Intensity Therapeutics raised $3.6M (Seed) on November 21, 2024.
  • Biofrontera raised $4.2M (Seed) on November 21, 2024.
  • Debiopharm raised $5.8M (Funding Round) on November 21, 2024.
  • HCW Biologics raised $6.9M on November 20, 2024.
  • Adipo Therapeutics raised $4.7M (Seed) on November 19, 2024.
  • Qualigen Therapeutics raised $5.1M on November 18, 2024.

Who to call at Booster Therapeutics, and when

A new round usually means Booster Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Booster Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Booster Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Booster Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Booster Therapeutics

Location

Berlin, Berlin, Germany

About

Booster Therapeutics is a biotechnology company focused on developing a new class of proteasome activator medicines for treating complex diseases, including neurodegenerative disorders. Founded by leading experts, the company aims to enhance the innate activity of proteasomes to combat the accumulation of harmful proteins in cells. With the support of significant financing, Booster is leveraging advanced technology to create a diverse pipeline of therapeutics. Its novel approach promises to address complex conditions that current protein degradation methods cannot effectively tackle.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Booster Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Booster Therapeutics's next move

See what Strategic adds

Booster Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.